Clinical Trial Update: A Trial Examining the Efficacy of Escitalopram Oxalate Upon Depressive Symptoms and Fatigue in HIV Seropositive Women [Phase 4]

View source ↗

Summary

A Phase 4 trial evaluating escitalopram oxalate for depressive symptoms and fatigue in HIV seropositive women was terminated; results were posted in 2013.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection
• Major Depressive Disorder

Drugs mentioned

• Escitalopram Oxalate (escitalopram oxalate)

Snippet

Sponsor: Duke University | Conditions: Depression, HIV | Phase 4 | Status: TERMINATED | Results posted: 2013-05-16